AskBiography Logo   Latest News  Follow Us on Twitter  Follow Us on Google Buzz  Became Fan - Facebook  Subscribe to RSSRSS   Bookmark and Share

     Home | Company | Mylan Inc



#REDIRECT Mylan







Mylan Inc Video

Citigroup analysts maintain their "buy" rating for Mylan Inc. (NYSE:MYL) and price target of $23. Analyst John Boris said, "We Expect MYL's Monopoly Generic Benzaclin Position (Launched 3Q09) &Generic Prevacid(Launched 11/10/09) to Drive 4Q09. MYL is also benefiting from Apotex cGMP manufacturing issues/import ban & a FX tailwind. Most of MYL's top 10 US products that we track (~87% of our '09E EPS) had modestly negative or declining growth at the end of 4Q09. We look for visibility/launch update on its 6&12 generic low-competition products targeted for 2H09&2010, respectively." Citigroup sees fiscal 2009 EPS of $1.29, vs. the consensus estimates of $1.27, and fiscal 2010 EPS of $1.64, vs. the consensus estimates of $1.54.
1.43 min. | 5.0 user rating
www.SupportLineAlerts.com This is today's BobChart for Mylan Inc. Mylan Inc closed at 10.47. The nearest support is 85.2 percent below the close at 1.55. The nearest resistance is 18.61 percent above the close at 12.42.
0.97 min. | 0 user rating
Visit www.optionshouse.com SPDR S&P 500 ETF (SPY), Mylan Inc. (MYL)
2.43 min. | 0 user rating

Latest News : Mylan Inc : Tweet this RSS

Want to Mylan Inc latest news on your twitter account???   sign in with twitter
Mylan Inc     sign in with twitter   ||  Company     sign in with twitter   ||  Economy     sign in with twitter
Mylan Q3 2010 Earnings Call Transcript - TheStreet.com Tweet this news
TheStreet.com--By Seeking Alpha 10/26/10 - 11:05 PM EDT Good day, and welcome to the -Mylan-, -Inc-. Third Quarter Fiscal 2010 Earnings Conference Call. ... - Date : Wed, 27 Oct 2010 22:14:30 GMT+00:00
Mylan says court won't block other Paxil generics - BusinessWeek Tweet this news
BusinessWeek--Generic drugmaker -Mylan Inc-. said that a US District Court has denied its request for a preliminary injunction to block other companies from selling ... - Date : Tue, 19 Oct 2010 19:31:55 GMT+00:00
Mylan Swings To 3Q Profit After 2009 Charges; Stock Down - Wall Street Journal Tweet this news
Wall Street Journal---Mylan Inc-. (MYL) swung to a third-quarter profit, topping Wall Street's forecasts, after charges last year and as sales climbed and margins increased. ... - Date : Tue, 26 Oct 2010 20:59:20 GMT+00:00
Mylan sales disappoint, shares fall - Reuters Tweet this news
Reuters--NEW YORK (Reuters) - -Mylan Inc- (MYL.O) said its third-quarter earnings were slightly above expectations, helped by new product launches in the United States ... - Date : Tue, 26 Oct 2010 21:12:24 GMT+00:00
Mylan: generic blood pressure drugs approved - BusinessWeek Tweet this news
BusinessWeek---Mylan Inc-. said Friday it received approval to start selling generic versions of Merck and Co.'s blood pressure drugs Cozaar and Hyzaar. ... - Date : Fri, 15 Oct 2010 19:33:39 GMT+00:00
Mylan prices senior notes to pay for Bioniche deal - BusinessWeek Tweet this news
BusinessWeek--Generic drugmaker -Mylan Inc-. said Friday it has priced senior notes due in 2020, from which it will use proceeds to help pay for its $550 million ... - Date : Sat, 31 Jul 2010 04:31:50 GMT+00:00
Mylan, Steptoe employees among top Manchin donors, report says - Charleston Gazette Tweet this news
Charleston Gazette--Mylan employees gave $92100 between 2000 and 2008, the institute found. Manchin's daughter, Heather Bresch, is president and CEO of -Mylan Inc-.--- - Date : Thu, 05 Aug 2010 03:59:29 GMT+00:00
New Issue-Mylan Inc adds $300 mln in notes - Reuters Tweet this news
Reuters--July 30 (Reuters) - -Mylan Inc- (MYL.O) on Friday added $300 million to existing senior notes in the 144a private placement market, said IFR, ... - Date : Fri, 30 Jul 2010 18:04:59 GMT+00:00
Mylan Inc prices add-on offering of USD300m senior notes - Trading Markets (press release) Tweet this news
Trading Markets (press release)--Specialist pharmaceutical company -Mylan Inc- (Nasdaq: MYL | PowerRating) said on Friday that the company has priced a USD300m aggregate principal amount of ... - Date : Mon, 02 Aug 2010 10:31:11 GMT+00:00
BOEHRINGER INGELHEIM INTERNATIONAL GMBH v. MYLAN PHARMACEUTICALS, INC. - Leagle.com Tweet this news
Leagle.com--Boehringer Ingelheim International GmbH and Boehringer Ingelheim Pharmaceuticals, -Inc-. move without opposition to vacate the May 12, 2009 order of the ... - Date : Tue, 03 Aug 2010 13:30:25 GMT+00:00



Privacy | Sitemap | Micra Hosting | USA Yellow Pages